scholarly journals The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

2021 ◽  
Author(s):  
Sarah A. Holstein ◽  
Nizar Bahlis ◽  
P. Leif Bergsagel ◽  
Manisha Bhutani ◽  
Niccolo Bolli ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Immune Profiling ◽  
Minimal Residual ◽  
Disease Testing

scholarly journals Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

Blood ◽  
2016 ◽  
Vol 127 (25) ◽  
pp. 3165-3174 ◽  
Author(s):  
Bruno Paiva ◽  
Maria-Teresa Cedena ◽  
Noemi Puig ◽  
Paula Arana ◽  
Maria-Belen Vidriales ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Prognostic Factors ◽  
Elderly Patients ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Disease Monitoring ◽  
Minimal Residual Disease Monitoring ◽  
Key Points ◽  
Immune Profiling ◽  
Minimal Residual

Key Points MRD monitoring is one of the most relevant prognostic factors in elderly MM patients, irrespective of age or cytogenetic risk. Second-generation MFC immune profiling concomitant to MRD monitoring also helped to identify patients with different outcomes.

scholarly journals Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity

Blood ◽  
2013 ◽  
Vol 122 (6) ◽  
pp. 1088-1089 ◽  
Author(s):  
Aaron Flanders ◽  
Maryalice Stetler-Stevenson ◽  
Ola Landgren
Keyword(s):  
Multiple Myeloma ◽  
Flow Cytometry ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Minimal Residual ◽  
Disease Testing
Sign in / Sign up

Export Citation Format

Share Document